glycyl-arginyl-glycyl-aspartyl-serine has been researched along with Carcinoma, Squamous Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dousaka-Nakajima, N; Fujii, K; Imamura, S | 1 |
1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-serine and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Epidermal growth factor enhancement of HSC-1 human cutaneous squamous carcinoma cell adhesion and migration on type I collagen involves selective up-regulation of alpha 2 beta 1 integrin expression.
Topics: Antigens, CD; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Adhesion; Cell Movement; Collagen; Epidermal Growth Factor; ErbB Receptors; Extracellular Matrix Proteins; Gene Amplification; Gene Expression Regulation, Neoplastic; Humans; Integrin beta1; Integrins; Oligopeptides; Skin Neoplasms; Tumor Cells, Cultured; Up-Regulation | 1995 |